跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial
Approved
STANDARD
PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial
Merck Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2be9f3ee2b69e480
Company
Merck Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
2be9f3ee2b69e480
Product Name
PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial
Artg Id
152797
Artg Name
PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial
Sponsor
Merck Healthcare Pty Ltd
Company Detail Path
/organization/merck-healthcare-pty-ltd
Artg Date
2009-11-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2be9f3ee2b69e480
Type
Standard
Back to TGA Approvals